ELEVANCE HEALTH/ US0367521038 /
- - | Chg. - | Volume | Bid3:00:48 AM | Ask3:00:48 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
400.30EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 92.66 bill.EUR | - | - |
Assets
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,944.3000 | 2,019.8000 | 1,977.9000 | 2,174.9000 | 2,735 | ||||||
Intangible Assets | 7,958.1000 | 8,158 | 7,964.9000 | 8,368.4000 | 9,007 | ||||||
Long-Term Investments | 2,231.8000 | 2,630.3000 | 2,796.3000 | 3,937.4000 | 4,213 | ||||||
Fixed Assets | 29,836.1000 | 30,855.7000 | 30,768.2000 | 34,277.2000 | 37,250 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | - | 11,943.6000 | 14,426.9000 | 14,978.2000 | 9,311 | ||||||
Cash and Cash Equivalents | 2,151.7000 | 2,113.5000 | 4,075.3000 | 3,608.9000 | 3,934 | ||||||
Current Assets | 32,228.9000 | 30,862.1000 | 34,314.9000 | 36,262.8000 | 34,321 | ||||||
Total Assets | 62,065 | 61,717.8000 | 65,083.1000 | 70,540 | 71,571 |
Liabilities
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | - | 10,888.6000 | 11,907.5000 | 13,015.9000 | 12,413 | ||||||
Long-term debt | 14,127.2000 | 15,324.5000 | 14,358.5000 | 17,382.2000 | 17,217 | ||||||
Liabilities to Banks | 400 | 540 | 440 | 1,275 | 1,145 | ||||||
Provisions | 3,897.3000 | 3,262.3000 | 3,446 | 2,373.8000 | 2,666 | ||||||
Liabilities | 37,813.7000 | 38,673.7000 | 39,982.7000 | 44,037.1000 | 43,030 | ||||||
Share Capital | - | 2.6000 | 2.6000 | 2.6000 | 3 | ||||||
Total Equity | 24,251.3000 | 23,044.1000 | 25,100.4000 | 26,502.9000 | 28,541 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 62,065 | 61,717.8000 | 65,083.1000 | 70,540 | 71,571 |
Income Statement
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 73,874.1000 | 79,156.5000 | 84,863 | 90,039.4000 | 92,105 | ||||||
Depreciation (total) | 220.9000 | 230.1000 | 192.3000 | 168.4000 | 358 | ||||||
Operating Result | 4,418.4000 | 4,753.1000 | 4,801.7000 | 4,175.4000 | 5,426 | ||||||
Interest Income | 600.7000 | -653 | -723 | -739 | -753 | ||||||
Income Before Taxes | 4,368.1000 | 4,631 | 4,555.4000 | 3,963.8000 | 5,068 | ||||||
Income Taxes | 1,808 | 2,071 | 2,085.6000 | 121 | 1,318 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 2,569.7000 | 2,560 | 2,469.8000 | 3,842.8000 | 3,750 |
Per Share
Cash Flow
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,369.3000 | 4,116 | 3,204.5000 | 4,184.8000 | 3,827 | ||||||
Cash Flow from Investing Activities | -974.9000 | -1,151.5000 | -513.9000 | -5,082.4000 | -1,259 | ||||||
Cash Flow from Financing | -1,822.5000 | -2,997.4000 | -732.9000 | 426.9000 | -2,241 | ||||||
Decrease / Increase in Cash | 564.8000 | -38.2000 | 1,961.8000 | -466.4000 | 325 | ||||||
Employees | 51,500 | 53,000 | 53,000 | 56,000 | 63,900 |